Form D · Pharmaceuticals

JJ PHARMA INC

San Francisco, CA · CIK 0001387599

Offering snapshot reported Dec 16, 2009 · SEC filing

Reported sold: $255K
Investors reported: 8
Minimum accepted: $0
First sale: Sep 5, 2009

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$70,001 → $255,002
Reported investors3 → 8

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Dec 16, 2009	Amendment	$255,002	$185,001vs Sep 21, 2009	8	SEC filing
Sep 21, 2009	Initial	$70,001	No comparison	3	SEC filing
Mar 13, 2007	Paper	Not reported	No comparison	Not reported	SEC filing
Jan 19, 2007	Paper	Not reported	No comparison	Not reported	SEC filing

Offering details

Securities: Not reported
Exemptions: 06
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-99237

Source: Form D, filed Dec 16, 2009. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Denis Burger	Director
Peter Colella	Director, Executive
Gleason Eakin	Director
Rom Eliaz	Director, Executive
Wayne Hamersly	Director
Ki Ingersol	Director, Executive
Josefino Tunac	Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:

505 Montgomery Street; 10 Th Floor
San Francisco, CA, 94111